FILTER

FILTERED INTERVIEW RESULTS

Travis Deti

EXECUTIVE DIRECTOR, WYOMING MINING ASSOCIATION (WMA)

"Wyoming is strategically positioned to address the geopolitical challenges affecting critical minerals, particularly in the uranium sector."

Greg Smith

PRESIDENT AND CEO, EQUINOX GOLD

"When operating at capacity, Greenstone will be our largest and lowest-cost mine, so we are really at a pivotal point in the company’s history."

United States

Pharma & Life Sciences

Anwar Daud

MANAGING DIRECTOR, ZIM LABORATORIES

"We progressed on the development of our New Innovative Products (NIP), which are complex generics developed using in-house proprietary technology platforms."

United States

Pharma & Life Sciences

India

Daniel Prince

CEO, PRINCE STERILIZATION SERVICES

"We are extremely excited about the growth our hydrogen peroxide and packaging segments can bring."

Mining

United States

Steve Trussell

EXECUTIVE DIRECTOR, ARIZONA MINING ASSOCIATION (AMA)

"Arizona has a favorable economic, political and regulatory climate. People know we are the ‘copper state’ and generally understand mining’s importance and the need for mined materials."

Mining

United States

Elly Perets

CEO, ASTERRA

"We have developed a model to enhance the efficiency of the exploration process by locating mineral deposits with greater precision and speed."

United States

Pharma & Life Sciences

Joe Panetta

PRESIDENT AND CEO, BIOCOM CALIFORNIA

"We are beginning to see California move forward as not two or three individual clusters, but rather as a powerhouse of integrated clusters, and this will continue to be our focus in the future."

Petrochemicals & Chemicals

Aaron Montgomery

PRESIDENT AND CEO, OURAY

"Being able to service this region from Singapore plays out as a significant advantage for us. With the future growth potential of China in question, I believe Southeast Asia will be the beneficiary."

United States

Pharma & Life Sciences

Kendalle Burlin O’Connell

CEO AND PRESIDENT, MASSBIO

"In 2023, Massachusetts made up just shy of 15% of the national drug development pipeline and approximately 7% of the global drug development pipeline."